Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Lancman

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Blood Cancer Discovery|September 28, 2023
IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific AntibodiesGuido Lancman, Kian Parsa, Krzysztof Kotlarz, et al.
Epilepsia|April 13, 2011
The value of intraoperative electrocorticography in surgical decision making for temporal lobe epilepsy with normal MRINeal Luther, Elayna Rubens, Nitin Sethi, et al.
Blood Advances|August 26, 2022
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myelomaTarek H Mouhieddine, Oliver Van Oekelen, David T Melnekoff, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Blood Cancer Discovery|September 28, 2023
IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific AntibodiesGuido Lancman, Kian Parsa, Krzysztof Kotlarz, et al.
Epilepsia|April 13, 2011
The value of intraoperative electrocorticography in surgical decision making for temporal lobe epilepsy with normal MRINeal Luther, Elayna Rubens, Nitin Sethi, et al.
Blood Advances|August 26, 2022
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myelomaTarek H Mouhieddine, Oliver Van Oekelen, David T Melnekoff, et al.
Pageof 4